No Drama Dendreon: Anticipated Provenge Launch Appears On Track
This article was originally published in The Pink Sheet Daily
Executive Summary
The biotech says it will launch prostate cancer vaccine the day after approval.
You may also be interested in...
PDUFA Cliffhanger: Will FDA End The Provenge Regulatory Saga?
FDA approval of Provenge for prostate cancer could come May 1, opening the door for the launch of the first cancer immunotherapy.
PDUFA Cliffhanger: Will FDA End The Provenge Regulatory Saga?
FDA approval of Provenge for prostate cancer could come May 1, opening the door for the launch of the first cancer immunotherapy.
Oncology Drug Reviews To Be Restructured As Office Shifts Away From Divisions Organized Around Molecule Size
FDA's Office of Oncology Drug Products is undergoing a reorganization aimed at making its structure more similar to the rest of the review offices in the Center for Drug Evaluation and Research